Antiretroviral cytolytic T-lymphocyte nonresponsiveness: FasL/Fas- mediated inhibition of CD4+ and CD8+ antiviral T cells by viral antigen- positive veto cells

Journal of Virology

Volumn 73, Issue 5, 1999, Pages 3826-3834

  Rich, Robert F ^a   Green, William R ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ANTIGEN SPECIFICITY; ANTIVIRAL ACTIVITY; ARTICLE; CELL DEATH; CELL TRANSFORMATION; CYTOTOXIC T LYMPHOCYTE; IMMUNE RESPONSE; MOLECULAR RECOGNITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; RETROVIRUS; T LYMPHOCYTE ACTIVATION; VIRUS EXPRESSION;

EID: 0032899594     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.73.5.3826-3834.1999     Document Type: Article

References (51)

1. Adachi, Y., N. Oyaizu, S. Than, T. W. McCloskey, and S. Pahwa. 1996. IL-2 rescues in vitro lymphocyte apoptosis in patients with HIV infection: correlation with its ability to block culture-induced down-modulation of Bc12. J. Immunol. 157:4184-4193.
2. Ameisen, J. C., and A. Capron. 1991. Cell dysfunction and depiction in AIDS: the programmed cell death hypothesis. Immunol. Today 12:102-105.
3. And, A., M. Buferne, C. Boyer, A. M. Schmitt-Verhulst, and P. Goldstein. 1994. T cell receptor-induced Fas ligand expression in cytotoxic T lymphocyte clones is blocked by protein tyrosine kinase inhibitors and cyciosporin A. Eur. J. Immunol. 24:2469-2476.
4. Banda, N. K., J. Bernier, D. K. Kurahara, R. Kurrle, N. Haigwood, R. P. Sekaly, and T. H. Finkel. 1992. Crosslinking CD4 by human immunodeficiency virus gp120 primes T cells for activation-induced apoptosis. J. Exp. Med. 176:1099-1106.
5. Berthou, C., L. Michel, A. Soulie, F. Jean-Louis, B. Flageul, L. Dubertret, F. Sigaux, Y. Zhang, and M. Sasportes. 1997. Acquisition of granzyme B and Fas ligand proteins by human keratinocytes contributes to epidermal cell defense. J. Immunol. 159:5293-5300.
6. Brunner, T., R. J. Mogil, D. LaFace, N. J. Voo, A. Mahboubi, F. Echeverri, S. J. Martin, W. R. Force, D. H. Lynch, and C. F. Ware. 1995. Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas. Nature 373:441-444.
7. b mice. Virology 202:500-505.
8. Coppola, M. A., T. M. Lam, R. R. Strawbridge, and W. R. Green. 1995. Recognition of ecotropic murine leukemia viruses by anti-AKR/Gross virus cytotoxic T lymphocytes: epitope variation in a CTL-resistant virus. J. Gen. Virol. 76:635-643.
9. + T cells. Proc. Natl. Acad. Sci. USA 93:11014-11018.
10. + T cells from human immunodeficiency virus-infected persons: differential in vitro preventive effect of cytokines and protease antagonists. Blood 87:4959-4966.
11. Fink, P. J., R. P. Shimonkevitz, and M. J. Bevan. 1988. Veto cells. Annu. Rev. Immunol. 6:115-137.
12. French, L. E., M. Hahne, I. Viard, G. Radlgruber, R. Zanone, K. Becker, C. Muller, and J. Tschopp. 1996. Fas and Fas ligand in embryos and adult mice: ligand expression in several immune-privileged tissues and coexpression in adult tissues characterized by apoptotic cell turnover. J. Cell Biol. 133:335-343.
13. French, L. E., A. Wilson, M. Hahne, I. Viard, J. Tschopp, and H. R. MacDonald. 1997. Fas ligand expression is restricted to nonlymphoid thymic components in situ. J. Immunol 159:2196-2202.
14. Gougeon, M.-L., S. Garcia, J. Heeney, R. Tschopp, H. Lecoeur, D. Guetard, V. Rame, C. Dauguet, and L. Montagnier. 1993. Programmed cell death in AIDS-related HIV and SIV infections. AIDS Res. Hum. Retroviruses 9:553-563.
15. b splenic B cells. J. Immunol. 131:3078-3084.
16. Green, W. R. 1984. Genetic control of the induction of cytolytic T lymphocyte responses to AKR/Gross viral leukemias. I. H-2 encoded dominant gene control. J. Immunol. 132:2658-2664.
17. h haplotype. J. Immunol. 132:2665-2671.
18. Green, W. R., R. C. Nowinski, and C. S. Henney. 1980. Specificity of cytolytic T cells directed against AKR/Gross virus-induced syngeneic leukemias: antibodies directed against H-2K, but not against viral proteins, inhibit lysis. J. Immunol. 125:647-655.
19. Green, W. R., and P. M. Smith. 1996. Endogenous ecotropic and recombinant MCF mouse retroviral variation and escape from antiviral CTL. Semin. Immunol. 7:49-60.
20. + T cells from human immunodeficiency virus-infected asymptomatic individuals. J. Exp. Med. 175:331-340.
21. Hahne, H., D. Rimoldi. M. Schroter, P. Romero, M. Schreier, L. E. French, P. Schneider, T. Bornand, A. Fontana, D. Lienard, J.-C. Cerottini, and J. Tschopp. 1996. Melanoma cell expression of Fas (Apo-1/CD95) ligand: implications for tumor immune escape. Science 274:1363-1366.
22. Hahne, M., T. Renno, M. Schroeter, M. Irmler, L. French, T. Bornand, H. R. MacDonald, and J. Tschopp. 1996. Activated B cells express functional Fas ligand. Eur. J. Immunol. 26:721-724.
23. Ju, S.-T., D. J. Panka, H. Cul, R. Ettinger, M. El-Khatib, B. H. Sherr, B. Z. Stanger, and A. Marshak-Rothstein. 1995. Fas (CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature 373:444-448.
24. Kishi, S., S. Saijyo, M. Arai. S. Karasawa, S. Ueda, M. Kannagi, Y. Iwakura, M. Fujii, and S. Yoneoara. 1997. Resistance to Fas-mediated apoptosis of peripheral T cells in human T lymphocyte virus type I (HTLV-I) transgenic mice with autoimmune arthropathy. J. Exp. Med. 186:57-64.
25. Meyaard, L., S. A. Otto, I. P. Keet, M. T. Roos, and F. Miedema. 1994. Programmed cell death of T cells in human immunodeficiency virus infection. No correlation with progression to disease. J. Clin. Investig. 93:982-988.
26. Owen, F. L., and G. M. Petermam. 1984. Neoplastic model for the differentiation of a subpopulation of lymphocytes bearing IgH-I-linked gene products. Immunol. Rev. 82:29-46.
27. Oyaizu, N., T. W. McCloskey, S. Than, R. Hu, V. S. Kalyanaraman, and S. Pahwa. 1994. Cross-linking of CD4 molecules upregulates Fas antigen expression in lymphocytes by inducing interferon-γ and tumor necrosis factor-α secretion. Blood 84:2622-2631.
28. Rammensee, H. G., M. J. Bevan, and P. J. Fink. 1985. Antigen specific suppression of T cell responses - the veto concept. Immunol. Today 6:41-43.
29. Rammensee, H. G., P. J. Fink, and M. J. Bevan. 1984. Functional clonal deletion of class I-specific cytotoxic T lymphocytes by veto cells that express antigen. J. Immunol. 133:2390-2396.
30. Ramsdell, F., M. S. Seaman, R. E. Miller, K. S. Picha, M. K. Kennedy, and D. H. Lynch. 1994. Differential ability of Th1 and Th2 T cells to express Fas ligand and to undergo activation induced cell death. Int. Immunol. 6:1545-1553.
31. bcongenic mice for anti-AKR/Gross MuLV CTL responses: involvement of inhibitory cells as defined by adoptive transfer experiments. Cell. Immunol. 160:139-151.
32. b lymphocytes inhibit the secondary in vitro cytotoxic T-lymphocyte response of primed responder cells to AKR/Gross murine leukemia virus-induced tumor cell stimulation. J. Virol. 70:402-414.
33. Rock, K. L., L. Rothstein, and S. Gamble. 1990. Generation of class 1 MHC-restricted T-T hybridomas. J. Immunol. 145:804-811.
34. Salmon, M., D. S. Toeliner, A. P. Huissoon, D. Pilling, N. Shamsadeen, H. Hyde, A. D. D'Angeac, P. A. Bacon, P. Emery, and A. N. Akbar. 1997. Inhibition of T cell apoptosis in the rheumatoid synovium. J. Clin. Investig. 99:439-446.
35. Sieg, S., D. Smith, Z. Yildirim, and D. Kaplan. 1997. Fas ligand deficiency in HIV disease. Proc. Natl. Acad. Sci. USA 94:5860-5865.
36. Sijts. A. J. A. M., F. Ossendorp, E. A. M. Mengede, P. J. van den Elsen, and C. J. M. Melief. 1994. Immunodominant mink cell focus-inducing murine leukemia virus (MuLV)-encoded CTL epitope, identified by its MHC class I-binding motif, explains MuLV-type specificity of MCF-directed T lymphocytes. J. Immunol. 152:106-116.
37. Strand, S., W. J. Hofmann, H. Hug, M. Muller, G. Otto, D. Strand, S. M. Mariani, W. Stremmel, P. H. Krammer, and P. R. Galle. 1996. Lymphocyte apoptosis induced by CD95 (APO-1/Fas) ligand-expressing tumor cells - a mechanism of immune evasion? Nat. Med. 2:1361-1366.
38. Suzuki, I., and P. J. Fink. 1998. Maximal proliferation of cytotoxic T lymphocytes requires reverse signaling through Fas ligand. J. Exp. Med. 187: 123-128.
39. Taswell, C. 1981. Limiting dilution assays for the determination of immunocompetent cell frequencies. I. Data analysis. J. Immunol. 126:1614-1619.
40. Thompson, C. B. 1995. Apoptosis in the pathogenesis and treatment of disease. Science 267:1456-1462.
41. Vella, A. T., J. E. McCormack, P. S. Linsley, J. W. Kappler, and P. Marrack. 1995. Lipopolysaccharide interferes with the induction of peripheral T cell death. Immunity 2:261-270.
42. Wang, Z. Q., A. Dudhane, T. Orlikowsky, M. K. Hoffmann, K. Clarke, X. Li, and Z. Darzynkiewicz. 1994. CD4 engagement induces Fas antigen-dependent apoptosis of T cells in vivo. Eur. J. Immunol. 24:1549-1552.
43. b mouse strains. Cell. Immunol. 113:308-319.
44. b mice. An analysis of precursor cytotoxic T lymphocyte frequencies in young versus moderately aged mice. J. Immunol. 146:2469-2477.
45. b and C57BL/6 mouse strains. J. Immunol. 149:1593-1598.
46. b-restricted peptide from the p15E transmembrane protein of endogenous ecotropic murine leukemia virus (MuLV) AKR623 that restores susceptibility of a tumor line to anti-AKR/Gross MuLV cytotoxic T lymphocytes. J. Virol. 68:897-904.
47. Xu, X.-N., G. R. Screaton, F. M. Gotcn, T. Dong, R. Tan, N. Almond, B. Walker, R. Stebbings, K. Kent, S. Nagata, J. E. Stott, and A. J. McMichael. 1997. Evasion of cytotoxic T lymphocyte (CTL) responses by Nef-dependent induction of Fas ligand (CD95L) expression on simian immunodeficiency virus-infected cells. J. Exp. Med. 186:7-16.
48. Yang, Y., M. S. Vacchio, and J. D. Ashwell. 1993.9-cis-Retinoic acid inhibits activation-driven T-cell apoptosis: implications for retinoid X receptor involvement in thymocyte development. Proc. Natl. Acad. Sci. USA 90:6170-6174.
49. Zettlmeissl, G., J.-P. Gregsersen, J. M. Duport. S. Mehdi, G. Reiner, and B. Seed. 1990. Expression and characterization of human CD4:immunoglobulin fusion proteins. DNA Cell Biol. 9:347-353.
50. Zhang, X., T. Brunner, L. Carter, R. W. Dutton, P. Rogers, L. Bradley, T. Sato, J. C. Reed, D. Green, and S. L. Swain. 1997. Unequal cell death in T helper (Th1) and Th2 effectors: Th1 but not Th2, effectors undergo rapid Fas/FasL-mediated apoptosis. J. Exp. Med. 10:1837-1849.
51. Zhang, X., L. Giangreco, H. E. Broome, C. M. Dargan, and S. L. Swain. 1995. Control of CD4 effector fate: transforming growth factor beta 1 and interleukin 2 synergize to prevent apoptosis and promote effector expansion. J. Exp. Med. 182:699-709.